Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research article

Development of a pharmaceutical care program in progressive stages in geriatric institutions

Authors: Conxita Mestres, Marta Hernandez, Anna Agustí, Laura Puerta, Blanca Llagostera, Patricia Amorós

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of integration of the pharmacist in the health care team. This work describes the evolution of the implementations of a program of pharmaceutical care centered in drug related problems (DRP) in a group of geriatric institutions of different levels of complexity.

Methods

Setting: Long-term and subacute care hospitals (HSS) and Health care teams attending nursing homes (EARs).
Participants: Patients attended in HSS and EARs during different periods between 2010 and 2016.
Interventions: The program was developed in different stages, in which pharmacists made interventions of increasing complexity.

Results

Between 2010 and 2013, the approach was only to improve the prescription of non-appropriate drugs for the elderly, which was reduced from 19 to 14.5%. Subsequent steps included detection of drug-related problems (DRP), systematization of treatment revisions, recording of pharmacist interventions, improvements in the classification of interventions and the creation of a web-based database for recording in a more efficient way.
During these years, there was an increase in the number of patients included in pharmaceutical care activities and thus the number of pharmacist interventions (3872 in 2014 vs 5903 in 2016). In 2016, mean age in 2016: 83.2 years old. Mean number of medicines/patient: 8.4 ± 3.3, and mean interventions/patient: 1.62. Degree of acceptance of the interventions by physicians improved (68.6% in 2016 vs 45.5% in 2012), even though there is still much work to do.
The Medication Appropriateness Index (MAI) showed that when the interventions were accepted, there was an important improvement. HSS mean MAI values pre-intervention: 2.52, post-intervention 0.80. In EARs: 5 pre and 1.39 post. In both cases p < 0.0001.

Conclusions

Approaching the deployment of activities in a progressive way has made us more efficient and able to confront and solve the problems that have arisen. Even though there has been a very restricted increase in the staff and budget, we are able to implement a DRP detection programme with guaranties of quality.
Literature
1.
go back to reference Brodie D. Societal needs for drugs and drug-related services. Am J Pharm Educ. 1980;44:276–8.PubMed Brodie D. Societal needs for drugs and drug-related services. Am J Pharm Educ. 1980;44:276–8.PubMed
2.
go back to reference Brodie D. The ninth annual rho chi lecture. Rep Rho Chi. 1973;39:6–12. Brodie D. The ninth annual rho chi lecture. Rep Rho Chi. 1973;39:6–12.
3.
go back to reference Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43. Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.
4.
go back to reference American Society of Hospital Pharmacy. ASHP statement on pharmaceutical care. Am J Hosp Pharm. 1993;50:1720–3. American Society of Hospital Pharmacy. ASHP statement on pharmaceutical care. Am J Hosp Pharm. 1993;50:1720–3.
5.
go back to reference American Society of Hospital Pharmacy. Implementing pharmaceutical care. Am J Hosp Pharm. 1993;50:1585–656. American Society of Hospital Pharmacy. Implementing pharmaceutical care. Am J Hosp Pharm. 1993;50:1585–656.
6.
go back to reference Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging [Internet]. 2016;33(3):199–204 Available from: http://link.springer.com/10.1007/s40266-016-0357-2.CrossRef Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging [Internet]. 2016;33(3):199–204 Available from: http://​link.​springer.​com/​10.​1007/​s40266-016-0357-2.​CrossRef
7.
go back to reference Beuscart JB, Dalleur O, Boland B, Thevelin S, Knol W, Cullinan S, et al. Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol. Clin Interv Aging [Internet]. 2017;12:1379–89 [cited 2017 Aug 31]. Available from: https://www.dovepress.com/development-of-a-core-outcome-set-for-medication-review-in-older-patie-peer-reviewed-article-CIA.CrossRef Beuscart JB, Dalleur O, Boland B, Thevelin S, Knol W, Cullinan S, et al. Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol. Clin Interv Aging [Internet]. 2017;12:1379–89 [cited 2017 Aug 31]. Available from: https://​www.​dovepress.​com/​development-of-a-core-outcome-set-for-medication-review-in-older-patie-peer-reviewed-article-CIA.​CrossRef
8.
go back to reference Ailabouni NJ, Nishtala PS, Tordoff JM. Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria. Eur Geriatr Med. 2016;7(1):40–6.CrossRef Ailabouni NJ, Nishtala PS, Tordoff JM. Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria. Eur Geriatr Med. 2016;7(1):40–6.CrossRef
9.
go back to reference Grion AM, Gallo U, Tinjala DD, Daragjati J, Loreggian M, Cardaci G, et al. A new computer-based tool to reduce potentially inappropriate prescriptions in hospitalized geriatric patients. Drugs Aging [Internet]. 2016;33(4):267–75 Available from: http://link.springer.com/10.1007/s40266-015-0340-3.CrossRef Grion AM, Gallo U, Tinjala DD, Daragjati J, Loreggian M, Cardaci G, et al. A new computer-based tool to reduce potentially inappropriate prescriptions in hospitalized geriatric patients. Drugs Aging [Internet]. 2016;33(4):267–75 Available from: http://​link.​springer.​com/​10.​1007/​s40266-015-0340-3.​CrossRef
10.
go back to reference Gallagher J, O’Sullivan D, McCarthy S, Gillespie P, Woods N, O’Mahony D, et al. Structured Pharmacist Review of Medication in Older Hospitalised Patients: A Cost-Effectiveness Analysis. Drugs Aging [Internet]. 2016;33(4):285–94 Available from: http://link.springer.com/10.1007/s40266-016-0348-3.CrossRef Gallagher J, O’Sullivan D, McCarthy S, Gillespie P, Woods N, O’Mahony D, et al. Structured Pharmacist Review of Medication in Older Hospitalised Patients: A Cost-Effectiveness Analysis. Drugs Aging [Internet]. 2016;33(4):285–94 Available from: http://​link.​springer.​com/​10.​1007/​s40266-016-0348-3.​CrossRef
11.
go back to reference Tallon M, Barragry J, Allen A, Breslin N, Deasy E, Moloney E, et al. Impact of the Collaborative Pharmaceutical Care at Tallaght Hospital (PACT) model on medication appropriateness of older patients. Eur J Hosp Pharm Sci Pract [Internet]. 2015:1–6 Available from: http://ejhp.bmj.com/lookup/doi/10.1136/ejhpharm-2014-000511. Tallon M, Barragry J, Allen A, Breslin N, Deasy E, Moloney E, et al. Impact of the Collaborative Pharmaceutical Care at Tallaght Hospital (PACT) model on medication appropriateness of older patients. Eur J Hosp Pharm Sci Pract [Internet]. 2015:1–6 Available from: http://​ejhp.​bmj.​com/​lookup/​doi/​10.​1136/​ejhpharm-2014-000511.​
13.
go back to reference Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen H. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRef Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen H. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRef
15.
go back to reference Investigations C. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc [Internet]. 2015;63:2227–46 Available from: http://doi.wiley.com/10.1111/jgs.13702.CrossRef Investigations C. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc [Internet]. 2015;63:2227–46 Available from: http://​doi.​wiley.​com/​10.​1111/​jgs.​13702.​CrossRef
17.
go back to reference Mestres C, Hernandez M, Llagostera B, Espier M, Chandre M. Improvement of pharmacological treatments in nursing homes: medication review by consultant pharmacists. Eur J Hosp Pharm. 2015;22(4):207–11.CrossRef Mestres C, Hernandez M, Llagostera B, Espier M, Chandre M. Improvement of pharmacological treatments in nursing homes: medication review by consultant pharmacists. Eur J Hosp Pharm. 2015;22(4):207–11.CrossRef
19.
go back to reference O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRef O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRef
20.
go back to reference Gallagher J, Stephen B, Woods N, Lynch Deirdre MS. Cost-outcome description of clinical pharmacists interventions in a university teaching hospital. BMC Health Serv Res. 2014;14:177.CrossRef Gallagher J, Stephen B, Woods N, Lynch Deirdre MS. Cost-outcome description of clinical pharmacists interventions in a university teaching hospital. BMC Health Serv Res. 2014;14:177.CrossRef
21.
go back to reference Sach TH, Desborough J, Houghton J, Holland R. Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older people. Int J pharm Pract [internet]. 2014:237–47 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25377218. Sach TH, Desborough J, Houghton J, Holland R. Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older people. Int J pharm Pract [internet]. 2014:237–47 Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25377218.
22.
go back to reference Mestres C, Agustí A, Hernandez M, Puerta L, Llagostera B. Estrategias de optimización de la prescripción en el paciente geriátrico. In: 60 Congreso SEFH; 2015. Mestres C, Agustí A, Hernandez M, Puerta L, Llagostera B. Estrategias de optimización de la prescripción en el paciente geriátrico. In: 60 Congreso SEFH; 2015.
23.
go back to reference Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Bereznicki LR. Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the Royal Hobart Hospital. Drugs Aging [Internet]. 2017;34(10):777–83 Available from: http://link.springer.com/10.1007/s40266-017-0490-6.CrossRef Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Bereznicki LR. Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the Royal Hobart Hospital. Drugs Aging [Internet]. 2017;34(10):777–83 Available from: http://​link.​springer.​com/​10.​1007/​s40266-017-0490-6.​CrossRef
Metadata
Title
Development of a pharmaceutical care program in progressive stages in geriatric institutions
Authors
Conxita Mestres
Marta Hernandez
Anna Agustí
Laura Puerta
Blanca Llagostera
Patricia Amorós
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-1002-1

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue